Publications

Publications

Filter Results: (79) Arrow Down

Show Results For

← Page 3 of 79 Results →
  • 11 Sep 2012
  • Working Paper Summaries

Spatial Organization of Firms: Internal and External Agglomeration Economies and Location Choices Through the Value Chain

Keywords: by Juan Alcácer & Mercedes Delgado
  • 01 Nov 2013
  • HBS Seminar

Eric Olson, Chief Scientific Officer at Syros Pharmaceuticals

  • Web

Faculty & Advisors | MBA

Harvard University; BA, Chemistry, Princeton University Hannah Chang is a Managing Director at Wu Capital, a global evergreen fund. Dr. Chang focuses on early-stage biopharmaceutical venture capital investments out of the firm’s San... View Details
  • 27 Sep 2011
  • First Look

First Look: September 27

which the ACA was passed and develops estimates of its likely impact on the biopharmaceutical industry. Universal insurance, either through a government-run system or by mandated purchase of private insurance, has been controversial in... View Details
Keywords: Sean Silverthorne
  • 16 Jul 2013
  • Working Paper Summaries

Visualizing and Measuring Enterprise Architecture: An Exploratory BioPharma Case

Keywords: by Robert Lagerstrom, Carliss Baldwin, Alan MacCormack & David Dreyfus
  • 14 Mar 2014
  • HBS Seminar

Jeremy M. Levin, former President and CEO, Teva Pharmaceutical Industries

  • 2008
  • Article

Industrial Specialization and Regional Clusters in the Ten New EU Member States

By: Orjan Solvell, Christian H.M. Ketels and Goran Lindqvist
Purpose—The purpose of this paper is to provide an analysis of regional concentration patterns within ten new European Union (EU) member states, EU10, and make comparisons with EU15 and the US economy.
Design/methodology/approach—Industrial... View Details
Keywords: Geographic Location; Policy; Employment; Industry Clusters; Industry Structures; European Union; United States
Related
  • Web

Sample Student Projects - Institute For Strategy And Competitiveness

Automotive Cluster (2012) Tirupur (India) Knitwear (2011) India (Maharashtra) Automotive Cluster (2010) Maharashtra Biopharmaceutical Cluster (2009) Bangalore Biotechnology (2008) Gujarat Diamonds (2008) Bollywood — Maharashtra and... View Details
  • Web

Academics - Health Care

interests in organizations that provide health care (e.g., hospitals, medical groups, retail clinics) or in firms that partner with, supply, consult to, or invest in such organizations (e.g., payers, biopharmaceutical and device... View Details
  • 09 Mar 2023
  • Blog Post

African American Student Union Spotlight on Joint Degrees

worked as a scientist in the Biotech and Biopharmaceutical industries. My role was focused on supporting the discovery and development of novel therapeutics for various neurological, infectious, and rare diseases, as well as oncology. At... View Details
  • Research Summary

Clinical Trials as a setting for Health Policy and Management Research

The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details

    Kiran Mazumdar-Shaw

    Keywords: Biopharmaceuticals
    • Fast Answer

    R&D expenditures: Companies

    -  R&D Activity Data series European Commission - Economics of Industrial Research and Innovation R&D Monitor See also (in print): Research & Development Growth Trends  In print: Ref T176 .R25  in Stamps Reading Room R&D... View Details
    • Web

    Litsa Kapsalis | MBA

    biopharmaceutical innovation by focusing on patient needs and building integrated teams, and I’m thrilled to learn from my creative, talented peers on our shared entrepreneurial journey. Tech areas of interest: Biotechnology, Precision... View Details
    • 16 Sep 2016
    • News

    Gaining Ground on ALS

    If you are one of the 17 million people who participated in the ALS Ice Bucket Challenge, the money you raised may be helping to fund a first-of-its kind clinical collaboration between a nonprofit patient/disease advocacy organization and a View Details
    • 27 Mar 2012
    • First Look

    First Look: March 27

    case:http://cb.hbsp.harvard.edu/cb/product/912030-PDF-ENG PAREXEL International Corp. (A) Regina E. Herzlinger and Natalie KindredHarvard Business School Case 311-068 Despite severe market turmoil, in 2001, the biopharmaceutical contract... View Details
    Keywords: Carmen Nobel
    • 22 Jul 2014
    • First Look

    First Look: July 22

    Corporate Finance Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company By: Knauer, Andrew, and George Serafeim Abstract—Faced with a large percentage of investors that... View Details
    Keywords: Sean Silverthorne
    • Web

    Transforming Health Care Delivery - Course Catalog

    consult to, or invest in such organizations (e.g., payers, biopharmaceutical and device companies, health information technology, venture capital and private equity). Educational Objectives This course will help students develop the... View Details
    • 28 Jul 2015
    • First Look

    First Look: July 28, 2015

    Value at IBM (A)." Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/215059-PDF-ENG Harvard Business School Case 215-079 Transforming Alkermes into a Global Biopharmaceutical Company In the summer of 2011, Jim Frates, CFO... View Details
    Keywords: Carmen Nobel
    • 22 Sep 2008
    • Research & Ideas

    The Silo Lives! Analyzing Coordination and Communication in Multiunit Companies

    electronic communication data, one at a leading biopharmaceuticals company and a second at a global media and professional services firm. One of these follows senior leaders through a period of reorganization, and the other contains... View Details
    Keywords: by Sarah Jane Gilbert